Market Overview

UPDATE: Cantor Fitzgerald Initiates Acadia Healthcare at Buy on Favorable Industry Trends

Share:
Related ACHC
5 Mid-Cap Healthcare Stocks With The Highest EPS Growth Forecast For Next 5 Years
Earnings Scheduled For February 11, 2015

Cantor Fitzgerald analyst Joseph D. France published a report on Acadia Healthcare (NASDAQ: ACHC), initiating coverage with a Buy rating and $35 price target.

Cantor Fitzgerald reported that, “We are initiating coverage of Acadia Healthcare with a BUY rating and $35 price target that values the company at roughly twice the acute care industry average, on both a P/E and EV/EBITDA (2014) basis, because of the more favorable regulatory environment for behavioral health services and the faster growth we expect Acadia to deliver as it capitalizes on changes in the market. Relative to other facilities-based behavioral health providers, we believe that Acadia is advantaged because it is the largest freestanding provider in the field. Our diluted EPS estimates are $1.00 in 2013 and $1.25 in 2014, compared with an adjusted $0.66 the company reported in 2012. Our $35 price target assumes that the stock can achieve a valuation of 11.6x our 2014 EBITDA estimate, which we believe potentially reflects Acadia's rapid growth in 2011-12, its competitive advantage, and industry trends that we believe are favorable.”

Shares of Acadia Healthcare closed at $28.04 on Tuesday.

Latest Ratings for ACHC

DateFirmActionFromTo
Feb 2015CitigroupMaintainsNeutral
Oct 2014Deutsche BankUpgradesHoldBuy
Oct 2014JefferiesMaintainsBuy

View More Analyst Ratings for ACHC
View the Latest Analyst Ratings

Posted-In: Cantor FitzgeraldAnalyst Color Initiation Analyst Ratings

 

Related Articles (ACHC)

Around the Web, We're Loving...